Skip to main content
. 2020 Apr 28;2020(4):CD013594. doi: 10.1002/14651858.CD013594

1.3. Analysis.

1.3

Comparison 1: Liposomal amphotericin B (lAmB) versus deoxycholate amphotericin B (dAmB), Outcome 3: Safety outcomes